Connection
Paul Bunn to Folic Acid Antagonists
This is a "connection" page, showing publications Paul Bunn has written about Folic Acid Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.873 |
|
|
|
-
Solomon B, Bunn PA. Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent. Future Oncol. 2005 Dec; 1(6):733-46.
Score: 0.259
-
Niyikiza C, Hanauske AR, Rusthoven JJ, Calvert AH, Allen R, Paoletti P, Bunn PA. Pemetrexed safety and dosing strategy. Semin Oncol. 2002 Dec; 29(6 Suppl 18):24-9.
Score: 0.211
-
Postmus PE, Bunn PA. Pemetrexed as a single agent in the therapy of advanced lung cancer. Semin Oncol. 2002 Apr; 29(2 Suppl 5):17-22.
Score: 0.201
-
Calvert H, Bunn PA. Future directions in the development of pemetrexed. Semin Oncol. 2002 Apr; 29(2 Suppl 5):54-61.
Score: 0.201